Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non Small Cell Lung Carcinoma NSCLC × CP protocol × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 1 Ovarian Neoplasms 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Non Small Cell Lung Carcinoma NSCLC 1 Lung Neoplasms 1

Interventions

durvalumab 1 Pemetrexed 1 Gemcitabine 1 Cisplatin 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003962 2026-03-11

Study of Durvalumab Alone or Chemotherapy for Patients With Advanced Non Small-Cell Lung Cancer (PEARL)

AstraZeneca

Phase 3 Active not recruiting

669 enrolled 54 charts

Non Small Cell Lung Carcinoma NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡